Trajectory of chemotherapy for patients with EGFR wild-type advanced pulmonary adenocarcinoma: a single-institution retrospective study

Trajectory of chemotherapy for patients with EGFR wild-type advanced pulmonary adenocarcinoma: a single-institution retrospective study

Seigo Minami, Yoshitaka Ogata, Shouichi Ihara, Suguru Yamamoto, Kiyoshi Komuta Department of Respiratory Medicine, Osaka Police Hospital, Osaka, Japan Background: Pulmonary adenocarcinoma, recently benefited by new cytotoxic and molecularly targeted drugs, has bee...

Full description

Bibliographic Details
Main Authors: Minami S, Ogata Y, Ihara S, Yamamoto S, Komuta K
Format: Article
Language:English
Published: Dove Medical Press 2017-02-01
Series:Lung Cancer : Targets and Therapy
Subjects:
adenocarcinoma
non-small cell lung cancer
first-line chemotherapy
second-line chemotherapy
third-line chemotherapy
epidermal growth factor receptor wild-type
Online Access:https://www.dovepress.com/trajectory-of-chemotherapy-for-patients-with-egfr-wild-type-advanced-p-peer-reviewed-article-LCTT

Internet

https://www.dovepress.com/trajectory-of-chemotherapy-for-patients-with-egfr-wild-type-advanced-p-peer-reviewed-article-LCTT

Similar Items